相关实验视频
Updated: Jan 23, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.8K
通过量化减弱指数 (QAI) 进行肝硬化症的非侵入性分期
Giovanni Galletti1, Elena Formisano2,3, Andrea Ghezzi1
1Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Minerva gastroenterology
|January 22, 2026
概括
量化减弱指数 (QAI) 可靠地评估肝脏肥胖症的非侵入性. 它与肝活检和受控衰减参数 (CAP) 对诊断与代谢功能障碍相关的脂肪性肝病 (MASLD) 有很好的一致性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医疗成像医学成像
- 诊断技术 诊断技术
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 可以导致肝硬化和肝细胞癌等严重的肝病.
- 非侵入性方法对于评估肝肥胖症至关重要,这是MASLD的一个关键组成部分.
研究的目的:
- 评估量化减弱指数 (QAI) 在评估肝硬化症时的准确性.
- 通过将其与肝脏活检 (黄金标准) 和受控衰减参数 (CAP) 进行比较,以确定QAI的诊断截止点.
主要方法:
- 一项前性研究,涉及209名患有慢性肝病的成年人,接受B模式超声波,QAI和CAP测量.
- 在指示时进行肝脏活检,作为组织学确认的黄金标准.
- 使用接收器操作特征 (ROC) 分析来确定诊断性能和QAI的截止值.
主要成果:
- 与其他肝脏疾病相比,MASLD患者的QAI和CAP显著更高.
- QAI在区分肥胖症等级方面表现出强大的诊断性能,任何肥胖症 (≥S1) 的AUROC为0.683,严重肥胖症 (S3) 的AUROC为0.925.
- QAI显示与CAP (κ=0.767) 有实质性的一致性,并且与肝活检 (r=0.719) 相比,与CAP (r=0.540) 有更好的相关性.
结论:
- 量化减弱指数 (QAI) 是一种可靠的非侵入性工具,用于评估肝硬化症.
- QAI与组织学发现和受控衰减参数 (CAP) 测量结果有很好的一致性.
- 作为MASLD评估的准确方法,QAI显示出前景.
更多相关视频
相关概念视频
Transcription Attenuation in Prokaryotes
18.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
Stages of General Anesthesia
1.6K
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.6K
Stages of Sleep
1.3K
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
1.3K

